CIK: 0001807489 · Show all filings
Period: Q4 2021 (Next →)
Filing Date: Feb 11, 2022
Total Value ($000): $128,064 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IVVD | ADAGIO THERAPEUTICS INC | 5,665,221 | $41,130 | 32.1% | $26.00 | 0.0% | COM | 00534A102 |
| STOK | STOKE THERAPEUTICS INC | 527,150 | $12,646 | 9.9% | $23.86 | 0.0% | COM | 86150R107 |
| — | CURIS INC | 2,608,851 | $12,418 | 9.7% | $4.76 | — | COM NEW | 231269200 |
| WVE | WAVE LIFE SCIENCES LTD | 3,765,588 | $11,824 | 9.2% | $4.15 | 0.0% | SHS | Y95308105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 495,280 | $10,812 | 8.4% | $27.28 | 0.0% | COM | 77313F106 |
| TGTX | TG THERAPEUTICS INC | 527,000 | $10,013 | 7.8% | $25.96 | 0.0% | COM | 88322Q108 |
| BBIO | BRIDGEBIO PHARMA INC | 466,200 | $7,776 | 6.1% | $42.31 | 0.0% | COM | 10806X102 |
| — | NEKTAR THERAPEUTICS | 560,600 | $7,574 | 5.9% | $13.51 | — | COM | 640268108 |
| — | ATARA BIOTHERAPEUTICS INC | 456,865 | $7,200 | 5.6% | $15.76 | — | COM | 046513107 |
| — | LEAP THERAPEUTICS INC | 1,000,000 | $3,240 | 2.5% | $3.24 | — | COM | 52187K101 |
| — | MIRATI THERAPEUTICS INC | 19,200 | $2,816 | 2.2% | $146.67 | — | COM | 60468T105 |
| — | NEXIMMUNE INC | 133,442 | $615 | 0.5% | $4.61 | — | COM | 65344D109 |